Veli Kairisto
Publications
- Efficacy of conventional-dose cytarabine, idarubicin and thioguanine versus intermediate-dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long-term results of the prospective randomized nationwide AML-2003 study by the Finnish Leukemia Group (2022)
- European Journal of Haematology
(A1 Refereed original research article in a scientific journal) - Gene fusions and oncogenic mutations in MLH1 deficient and BRAFV600E wild-type colorectal cancers (2022)
- Virchows Archiv
(A1 Refereed original research article in a scientific journal) - Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study (2022)
- Leukemia
(A1 Refereed original research article in a scientific journal) - Tool evaluation for the detection of variably sized indels from next generation whole genome and targeted sequencing data (2022)
- PLoS Computational Biology
(A1 Refereed original research article in a scientific journal) - Geeniohjatun syövän hoidon työryhmä hoitopäätösten apuna : Läntisen syöpäkeskuksen kokemus (2021)
- Duodecim
(D1 Article in a professional journal) - Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia (2020)
- British Journal of Haematology
(A1 Refereed original research article in a scientific journal) - Arpp19 Promotes Myc and Cip2a Expression and Associates with Patient Relapse in Acute Myeloid Leukemia (2019)
- Cancers
(A1 Refereed original research article in a scientific journal) - Hematologisen syöpäpotilaan diagnostinen polku (2019)
- Duodecim
(D1 Article in a professional journal) - Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (2019)
- Leukemia
(A1 Refereed original research article in a scientific journal) - Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial (2018)
- Lancet Oncology
(A1 Refereed original research article in a scientific journal) - Measurable Residual Disease Assessment By qPCR in Peripheral Blood Is an Informative Tool for Disease Surveillance in Childhood Acute Myeloid Leukemia (2018)
- Blood
(Other publication) - Syväsekvensoinnilla verisyövän täsmädiagnoosiin ja yksilöllistettyyn hoitoon (2017)
- Kliin lab
(D1 Article in a professional journal) - Syväseskvenssoinnilla verisyövän täsmädiagnoosiin ja yksilöllistettyyn hoitoon (2017)
- Kliin lab
(D1 Article in a professional journal) - A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR (2015)
- Leukemia
(A1 Refereed original research article in a scientific journal) - Comparative analysis of minimal residual disease detection by multiparameter flow cytometry and enhanced ASO RQ-PCR in multiple myeloma (2014)
- Blood Cancer Journal
(A1 Refereed original research article in a scientific journal) - Interim Analysis of a Pan European Stop Tyrosine Kinase Inhibitor Trial in Chronic Myeloid Leukemia : The EURO-SKI study (2014)
- Blood
(Other publication) - Assessment of molecular remission rate after bortezomib plus dexamethasone induction treatment and autologous stem cell transplantation in newly diagnosed multiple myeloma patients (2013)
- British Journal of Haematology
(B1 Non-refereed article in a scientific journal) - Establishment of the first World Health Organization international genetic reference panel for quantitation of BCR-ABL mRNA (2010)
- Blood
(A1 Refereed original research article in a scientific journal) - ETS-related gene ERG expression in AML patients is significantly associated with NPM1 mutation status (2010)
- European Journal of Haematology
(A1 Refereed original research article in a scientific journal) - Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy (2010)
- Blood
(A1 Refereed original research article in a scientific journal)